US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Rhythm Biosciences Limited (RHY) 銘柄情報

Rhythm Biosciences Limited (RHY)

0.105

-0.01

( -8.70% )

更新日時： 12:29:04

Rhythm Biosciences Limited (RHY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.105

( -8.70% )

買値

0.105

売値

0.115

出来高

135,244

0.105 日の範囲 0.12

0.047 52 週間の範囲 0.28

時価総額

前日終値

0.115

始値

0.115

時刻

最終取引時間

12:29:04

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 586,239

発行済株式数

353,866,857

配当利回り

PER

-4.72

1 株当たり利益 (EPS)

-0.02

歳入

1.65M

純利益

-6.68M

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic ... Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

rhythmbio.com

本社

Parkville, Australia

設立

2026

Rhythm Biosciences Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker RHY. The last closing price for Rhythm Biosciences was AUD0.12. Over the last year, Rhythm Biosciences shares have traded in a share price range of AUD 0.047 to AUD 0.28.

Rhythm Biosciences currently has 353,866,857 shares in issue. The market capitalisation of Rhythm Biosciences is AUD37.16 million. Rhythm Biosciences has a price to earnings ratio (PE ratio) of -4.72.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.105	0.12	0.105	225447	0.11395355	DE
4	-0.04	-27.5862068966	0.145	0.145	0.105	477925	0.1244714	DE
12	-0.11	-51.1627906977	0.215	0.25	0.105	555880	0.16497786	DE
26	0.029	38.1578947368	0.076	0.28	0.075	806028	0.17222452	DE
52	0.043	69.3548387097	0.062	0.28	0.047	678959	0.13812831	DE
156	-0.395	-79	0.5	0.555	0.042	386344	0.1394368	DE
260	-0.885	-89.3939393939	0.99	2.08	0.042	333317	0.41598498	DE

RHY - Frequently Asked Questions (FAQ)

What is the current Rhythm Biosciences Limited share price?

The current share price of Rhythm Biosciences Limited is AUD 0.105

How many Rhythm Biosciences Limited shares are in issue?

Rhythm Biosciences Limited has 353,866,857 shares in issue

What is the market cap of Rhythm Biosciences Limited?

The market capitalisation of Rhythm Biosciences Limited is AUD 37.16M

What is the 1 year trading range for Rhythm Biosciences Limited share price?

Rhythm Biosciences Limited has traded in the range of AUD 0.047 to AUD 0.28 during the past year

What is the PE ratio of Rhythm Biosciences Limited?

The price to earnings ratio of Rhythm Biosciences Limited is -4.72

What is the cash to sales ratio of Rhythm Biosciences Limited?

The cash to sales ratio of Rhythm Biosciences Limited is 22.55

What is the registered address of Rhythm Biosciences Limited?

The registered address for Rhythm Biosciences Limited is Bio21 Institute, Parkville, Victoria, 3010

What is the Rhythm Biosciences Limited website address?

The website address for Rhythm Biosciences Limited is rhythmbio.com

Which industry sector does Rhythm Biosciences Limited operate in?

Rhythm Biosciences Limited operates in the Medical Diagnostics & Screening sector

barnstormer

barnstormer 1分前

Lolo, if you'll actually do some checking, I believe you'll find the FDA real world data issue is just someone's opinion as is the claim the FDA currently requires a closed system. Don't believe me, look it up it yourself.

joe botts

joe botts 13分前

Lol!!! So call Wertheim let me know how that goes? Lmao

sloppyjones

sloppyjones 14分前

This sounds promising!
https://www.linkedin.com/posts/jean-marc-herbet-97b4237a_vumelive-vumehongkong-worldcup2026-share-7470300813957971968-1a26/?utm_source=share&utm_medium=member_android&rcm=ACoAAAm5fn0BNNCgxoNsCsVMeAJ5eEU9hqPLf74

1kgwxman

1kgwxman 14分前

Why are you asking an investor for something only AMFN can provide?
If AMFN is too risky, then don't buy.
Penny stocks are risky.
Or wait until autumn and you'll have your answers.
I'm using gambling funds, so I'm fine with that risk.

Geez man...

NoMoDo

NoMoDo 16分前

I firmly believe that RWAX has incredible potential to be a great company. Not there yet, but potential. I want to provide my opinions on the company, both positive and negative, but I have decided that I won't post on Ihub again until my posting restrictions have been removed. I don't expect tha

surfkast

surfkast 17分前

Legal charges for what? 🤣

surfer44

surfer44 19分前

Offshore oil is booming. So are the Chinese companies that make the equipment for it.

https://youtu.be/9Xhr_Wdzej4

govprs

govprs 20分前

I’m with you dog! I like under .02 and been quietly adding 20-40k at a time. I have no consistency i just place the chips on the table now and then waiting for the deal come round.
Patience is so important I tell myself 😂😎
Good luck to all the good guys and gals on th

surfkast

surfkast 22分前

Claims of cancer which knows no age.

weedtrader420

weedtrader420 23分前

EVERLONG XRP 👊FOO FIGHTERS TIME LIKE THESE $100 target let them drop it a lot of money sitting on the sideline waiting to come in🤑

surfkast

surfkast 24分前

I have been saying that for months. When I saw he was not racing I looked up his horses. Many were gone from his stable . Sadly he spent a million on just three horses when he started his shell games.

europa7

europa7 25分前

EU Digital Product Passport Impact on US Supply Chains
"...DPPs begin in 2027, requiring standardized identifiers, secure data systems, and lifecycle tracking for goods sold in European markets..."
April 30, 2026
https://www.packagingdigest.com/regulations-standards/eu-digital-p

DredLock

DredLock 28分前

Craig Marshak is now officially the CEO of Wertheim & Co. Craig was named 'CEO' of GBT only because GBT will transition into Wertheim & Co. with Craig Marshak as CEO. GBT will be history. Patrick is interim CEO because soon GBT will become Wertheim and there will be no need for Patrick. Joe Botts,

Helter Skelter

Helter Skelter 29分前

But I do care 😺 about
$1,000,000,000 hitting our bottom line!

BB is estimated to earn ~18¢ for FY 2027.

585M OS / .18 = $105,000,000 profit for 2027.

I'm looking forward to Malikie adding $100 million to our
bot

King-of-Huns

King-of-Huns 31分前

I did a bit DD on how & when companies needs to file even if they are on Xpert

randychub

randychub 32分前

Gemini says basically the same thing - PFE will successfully argue for a heavily discounted royalty rate (1.5 to 2%) for 2022. They will leverage the factors to prove that the immense revenue was driven by Pfizer's unprecedented global manufacturing scale and risk-taking during a public health em

porty

I haven’t seen any gvsi communications. What were they? I see srnw had a 600,000 share update today on otcmarkets.

tdbowieknife

tdbowieknife 36分前

With the science of fusion you don't go to working fusion first try.... Where are the papers for the previous "prototypes"???

Geeezzz man...

.

.

Watch your wallet

Buyer Beware
Social Media Prom

EarningsCentral

EarningsCentral 38分前

Lolo_Ferrari

Lolo_Ferrari 41分前

Britain is not socialist 😂😂😂 Thatcher decentralized government control in the 80s. Clueless 🤦🏻

The FDA won't even entertain our trial data in its current form, a least the Communist States of the British Isles is looking at it. 🤣

Reregistered

Reregistered 42分前

Nobody selling. BIG indicator!!!

1manband

1manband 42分前

He races all over. Mostly in Southern California, but his lower level horses can race at Turf Paradise in Phoenix in the Winter. He also keeps stakes horses back east, and regularly races on the Kentucky circuit, such as Churchill and Keeneland, and in Florida, and the Mid-Atlantic circuit.

1kgwxman

1kgwxman 42分前

Your timeline forgets that this event is still in the future, not the present.
The 5mw Texatron will be assembled off the new pre-production frame that AMFN says will be delivered next week.

Today's pr clearly stated a timeline to debut the Texatron.
END OF AUGUST!!!

Reregistered

Reregistered 43分前

1 share okay!! means no one is selling. Super bright side to all of this. No one is selling other than mm manipulation.

Rhythm Biosciences

BNP Paribas Issuance

BSD vs US Dollar

Hardwoods Distribution

Dax Global Bric Net Tota...

DBIX India Index Perform...

Millenmin Ventures

Mitsubishi Pencil (PK)

Global Ship Lease

Insight Enterpr Dl 01

Royal Bank of Canada Aut...

Alchemy Resources

Mincor Resources Nl

Ci International Value C...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。